Sure Topline Outcomes for Unique Cervical Dystonia Treatment

Sure Topline Outcomes for Unique Cervical Dystonia Treatment

Uncategorized

DaxibotulinumtoxinA for treatment of cervical dystonia met the principle and secondary endpoints in the ASPEN-1 phase 3 trial, Revance Therapeutics reports. Medscape Scientific Recordsdata
Read Extra

Leave a Reply

Your email address will not be published. Required fields are marked *